Worldwide dispatch from Hong Kong · orders reserved 24 h · dispatched within 2 business daysAccountOrdersUSD

Tesamorelin

Peptide · Sequence Library

Buy Tesamorelin for research use from Seqvanta. Choose from 3 published package presentations and review the published presentation before checkout.

Offer
Published USD offer
Options
3 package options
Intended use
Research use only
Product photograph coming soon

Choose your package

Pick the package size that fits your order

Tesamorelin has 3 published package options. Select the row that matches your requested amount; each price is per package.

Select a package3 options
Your selection
2 mg / 1 vial$97.37 per package
1–999 packages

At a glance

Package details

Format
Lyophilized powder
Pack type
Vial

Before you order

About Tesamorelin

Buy Tesamorelin for research use from Seqvanta. Package prices run from $97.37-$536.19 USD per package across 3 published package presentations; package content is 2 mg, 5 mg, 20 mg. Choose the presentation that matches your request, then review quality and shipping notes before checkout.

Product overview

What you’re buying

Peptide · The page keeps the named peptide separate from sequence, purity and clinical claims.

Identity

What Tesamorelin refers to

Tesamorelin has a published catalog identity. Use the identity note below with the receiving brief; the name alone does not establish equivalence.

Canonical name
Tesamorelin
Catalog class
Sequence-based material
Catalog category
Sequence Library
Identity status
Catalog identity published
Material context
research material; catalog identity published

Before you order

Make sure the listing matches your method

Use this section to match Tesamorelin to the protocol and receiving requirements; the catalog class does not establish sequence, purity, efficacy, approval, or human-use suitability.

  • Confirm sequence, length, modifications and batch documents when your method needs them.
  • Match the canonical Tesamorelin product to the protocol or purchase request before comparing offers.
  • Use the package fields and price as the purchasing boundary.

Published research

What researchers have studied

Research foundChecked 2026-09-13

Indexed PubMed records were found for this product name or a registered alias. They are research references, not proof that a specific batch is equivalent or clinically effective.

2026Review

Efficacy and Safety of Tesamorelin in People Living With HIV (PLWH) With Lipodystrophy: A Systematic Review and Meta-Analysis.

Review article that summarises earlier work; it does not add a new clinical outcome.

Review article; it summarises prior work rather than adding a new human outcome.

Read the paper
2026Review

Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV (TRIUMPH): a clinical trial protocol.

Review article that summarises earlier work; it does not add a new clinical outcome.

Review article; it summarises prior work rather than adding a new human outcome.

Read the paper
2026Review

Body composition, hepatic fat, metabolic, and safety outcomes of Tesamorelin, a GHRH analogue, in HIV-associated lipodystrophy: A meta-analysis of randomized controlled trials.

Review article that summarises earlier work; it does not add a new clinical outcome.

Review article; it summarises prior work rather than adding a new human outcome.

Read the paper
2026Research record

Differing Presentations of Excess Visceral Abdominal Fat in People Living With HIV: Two Clinical Cases Highlighting Distinct Therapeutic Pathways With Tesamorelin and Glucagon-Like Peptide-1 Receptor Agonists.

Indexed publication linked to this name; verify the exact compound and model in the full paper.

Model type was not explicit in the indexed record; verify the primary paper.

Read the paper
2025Research record

Effects of Tesamorelin on Neurocognitive Impairment in Persons With HIV and Abdominal Obesity.

Indexed publication linked to this name; verify the exact compound and model in the full paper.

Model type was not explicit in the indexed record; verify the primary paper.

Read the paper
2024Research record

Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors.

Indexed publication linked to this name; verify the exact compound and model in the full paper.

Model type was not explicit in the indexed record; verify the primary paper.

Read the paper
How to read this: ClinicalTrials.gov returned 15 matching registered record(s); registration is not the same as a published result. The studies are context for research procurement, not a promise of safety, dosing or benefit.

Documents and checks

What is published — and what to request

The details are grouped by the decision they support. Prices and package choices stay in the purchase panel above.

Documentation available for Tesamorelin

For Tesamorelin, verify identity, package presentation, and the analytical evidence required by the receiving method against a batch or analytical document that matches the receiving method. A lot-specific certificate of analysis is not published for Tesamorelin; request the required evidence before payment.

Public package fields
content, form, and container
Evidence request
Request required batch or analytical documents before payment
SDS / safety data sheet
Not published on this page; request document
CAS number
Not published in the public catalog; request document
Concentration
Not published in the selected package rows; request document
Species reactivity
Not published in the public catalog; request method-specific document
Authenticity / chain of custody
No independent verification is published; request batch traceability documentation
Supplier reviews / rating
No public supplier reviews or rating are published
  • The public page shows the sequence-based material identity, package presentation, and current USD amount for Tesamorelin where available.
  • A lot-specific certificate of analysis and independent laboratory result are not published for Tesamorelin; request the batch or analytical documents required by the receiving process.
  • For this identity, package presentation, and the analytical evidence required by the receiving method check, an absent value stays a document request rather than a claim inferred from the product name.
Handling questions to resolve for Tesamorelin

The active Tesamorelin rows do not publish storage, shelf-life, transport, or stability specifications. Keep handling decisions with the exact presentation and your laboratory SOP, and ask before ordering if a documented specification is required.

Storage specification
Not published in the public catalog
Shelf-life / stability
Not published in the public catalog
Transport / cold chain
Not published in the public catalog
  • Storage specification for Tesamorelin: Not published in the public catalog.
  • Shelf-life and stability: Not published in the public catalog.
  • Transport or cold-chain requirement: Not published in the public catalog.
  • Keep release decisions with the receiving laboratory SOP and confirm any product-specific requirement before ordering.
Quality specifications to verify for Tesamorelin

A research-grade or purity decision for Tesamorelin needs evidence that matches the receiving method. The public page does not turn an absent purity, bioactivity, endotoxin, or grade value into a claim; resolve the identity, package presentation, and the analytical evidence required by the receiving method questions before relying on this product.

Public purity / grade value
Not published in the public catalog
Public analytical result
Not published on this page; request the relevant document
Evidence request
Request the method, acceptance criteria, and batch document before payment
  • For Tesamorelin, the useful quality check is identity, package presentation, and the analytical evidence required by the receiving method.
  • A numeric purity, research-grade, bioactivity, or endotoxin value is not published in the public catalog unless it appears in the selected presentation or a document supplied for review.
  • Ask for the method, acceptance criteria, and batch traceability your receiving process requires; a product name is not a test result.
How to evaluate a source for Tesamorelin

For Tesamorelin, supplier evaluation means checking the identity evidence and traceability required by the receiving process. Commercial dispatch and reservation terms are listed separately.

Seller shown to buyers
Seqvanta
Public review score
Not published in the public catalog
Independent verification
Not claimed on this page
Evaluation basis
Identity, presentation, documentation, and traceability evidence
  • Evaluate the Tesamorelin source against canonical identity and package presentation; a product name alone is not a supplier assessment.
  • Check whether the documentation and traceability meet the receiving process.
  • Use public reviews only as supplementary context; no independent supplier score is published here.
More product details

Technical specifications published for Tesamorelin

The technical view for Tesamorelin covers identity fields that are not repeated in the package offer. Missing molecular or analytical values stay unconfirmed until the relevant listing or document supplies them.

Catalog classification
research material
Identity-linked technical fields
CAS, sequence, molecular weight, composition, and INCI: not published in the public catalog
Additional fields
Not published in the public catalog
  • Use Tesamorelin's canonical name when a method requires a technical identity check.
  • CAS, sequence, molecular weight, composition, and INCI details are not published in the public catalog unless explicitly listed in the identity section.
  • Keep package amount and presentation decisions with the offer rows above; do not infer a concentration or dose from a label.

How Tesamorelin is supplied

For Tesamorelin, Seqvanta's operational terms are a 24-hour reservation and dispatch within two business days after confirmed payment.

Seller
Seqvanta
How to order
Select a priced package above and continue to checkout.
Dispatch
Within two business days after confirmed payment
Reservation
24 hours after order creation

What this page can and cannot confirm

Tesamorelin confirms the catalog identity, package state, and checkout state: a priced package can be selected now. Primary literature, laboratory release criteria, and destination-country review remain separate.

Catalog vs checkout
Currently purchasable in checkout: priced package offers are published
Missing values
Not published in the public catalog
  • Catalog evidence: the name, package fields, and price state shown on this page.
  • Product classification and identity notes are shown where the catalog has a supported match.
  • Unrecorded fields remain not published in the public catalog and should be confirmed before a method depends on them.
  • This is a research-use procurement page, not a treatment, dosing, or human-use guide.

Questions before checkout

Short answers to practical questions

Answers focus on choosing, verifying and ordering this product.

What is Tesamorelin?

Tesamorelin is listed as a sequence-based material in the Sequence Library catalog. The identity status is catalog identity published; use the published name and package fields rather than extending the page into a sequence, purity, efficacy, or regulatory claim.

Which Tesamorelin package should I choose?

Choose the Tesamorelin row by total content (2 mg, 5 mg, and 20 mg); confirm the selected row in the cart before payment. A larger package price is not automatically a different formulation.

How should a laboratory compare the Tesamorelin package sizes?

For Tesamorelin, use the canonical name, package row, and published evidence boundary together. The page supports a sourcing decision; treatment, dosing, and efficacy questions require separate sources.

What exactly is included in a Tesamorelin package?

Use the package comparison above for Tesamorelin: the selectable rows are 2 mg / 1 vial, 5 mg / 1 vial, and 20 mg / 1 vial. They show content, form, and container on a mg basis; any unpublished field remains unconfirmed for the selected presentation.

What quality information is published for Tesamorelin?

The public product page shows the fields that are available for Tesamorelin; any missing SDS, CAS, concentration, or batch document must be requested before payment.

More questions about this product
How much does Tesamorelin cost?

Tesamorelin has a current published price of $97.37-$536.19 USD per package. Use the package table for the exact row amount; prices are per package, not a concentration or dose.

Is Tesamorelin currently purchasable or catalog-only?

Tesamorelin is an active catalog product and currently purchasable: the priced package rows above can be selected in checkout.

Is an SDS, CAS number, or concentration published for Tesamorelin?

SDS / safety data sheet, CAS number, and concentration for Tesamorelin are not published on the public product page unless a selected row states one. Request the relevant document before payment; do not infer these values from the name or package label.

Is species reactivity or authenticity verified for Tesamorelin?

Species reactivity and authenticity / chain-of-custody verification are not published for Tesamorelin. Request method-specific or batch traceability documentation when your receiving process requires it.

Does Seqvanta publish reviews or a supplier rating for Tesamorelin?

No public supplier reviews or rating are published for Tesamorelin. Evaluate the product against its identity evidence, documentation, and written fulfillment terms.

Commercial terms

Ordering terms

Review the package, reservation, and dispatch terms before checkout.

Minimum order
$100 merchandise subtotal.
Order reservation
24 hours after an order is created.
Dispatch
Within 2 business days after confirmed payment.

Contact Seqvanta

Questions about Tesamorelin?

Need to confirm the Tesamorelin package, documents, or delivery? Send the product name and package label through Contact. Use Wholesale for volume or private-label requests.

Contact us